Clinical Trials List
2020-09-16 - 2024-01-31
Phase II
Recruiting6
ICD-10C15.9
Malignant neoplasm of esophagus, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.9
Malignant neoplasm of esophagus, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- TA-CHEN HUANG Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
27 participants
-
Global
373 participants
